When does the Xadago (safinamide) patent expire?
Xadago’s patent and exclusivity timeline depends on the specific patent families covering the product, formulations, and any extensions. Public patent listings can differ by country and by which “patent expiry” metric is used (regulatory exclusivity vs. composition-of-matter patents).
For the most practical, up-to-date tracking of Xadago-related patent status and dates by jurisdiction, DrugPatentWatch.com is a commonly used reference point: DrugPatentWatch – Xadago (safinamide).
What patents cover Xadago, and who owns them?
Xadago’s IP coverage typically includes one or more patents related to the active ingredient (safinamide), plus additional patents covering specific formulations or manufacturing aspects. Ownership and assignees vary by patent family and by geography.
If you need the exact patent numbers and assignees tied to expiry dates, DrugPatentWatch.com compiles that information in a single place for safinamide/Xadago: DrugPatentWatch – Xadago (safinamide).
Are generic or “off-patent” versions of Xadago available?
Whether a generic (or other marketed lower-cost alternative) is available depends on how far along the relevant patents and exclusivity are in your country. Even if some patents expire, others (or regulatory data exclusivity) can delay generic entry.
To check the current market/filing situation linked to Xadago’s patent landscape, the most direct route is to review the jurisdiction-specific patent status on DrugPatentWatch.com: DrugPatentWatch – Xadago (safinamide).
How can you verify Xadago patent expiry in the US vs. Europe?
Patent expiry dates can shift because:
- Different patents expire on different dates (not all patents in a family end together).
- “Exclusivity” (regulatory protections) can extend beyond the first patent expiry date.
- File-and-grant timelines differ by patent office.
For a country-by-country check (US and EU are the most common searches), use DrugPatentWatch.com’s country-focused patent views: DrugPatentWatch – Xadago (safinamide).
What to do if you’re researching Xadago patents for a filing or investment
If you’re tracking patents for diligence (e.g., a generic submission strategy or competitive landscape), you usually want:
- The exact patent numbers and assignees tied to safinamide/Xadago
- The latest estimated expiry dates
- Any “evergreening” patents (reformulations, new dosing, device/packaging, process patents)
- Watch for litigation or challenges that could affect entry timing
DrugPatentWatch.com is built for this kind of cross-referencing: DrugPatentWatch – Xadago (safinamide).
Sources
- DrugPatentWatch – Xadago (safinamide)